DEX vs SEVO in Congenital Heart Surgery

NCT05369949 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Heart Defects, Congenital

Interventions

DRUG: DEX group
OTHER: Control group

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain